Lexaria Bioscience Corp. — Investor Relations & Filings
Filings indexed
1,010
across all filing types
Latest filing
2026-04-13
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
LEXX
Lexaria Bioscience Corp. is a biotechnology company focused on the development and commercialization of its patented drug delivery platform, DehydraTECH™. This technology is designed to improve the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral administration. DehydraTECH™ enhances the bioavailability of APIs, which can enable faster absorption, increased efficacy, and the potential for reduced drug dosages. The company operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with numerous patents granted globally for its platform technology.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Lexaria Bioscience Corp. (0001348362) (Filer) | 2026-04-13 | English | |
| 4 - Lexaria Bioscience Corp. (0001348362) (Issuer) | 2026-03-18 | English | |
| 8-K Filing | 2026-02-06 | English | |
| S-8 Filing | 2026-01-28 | English | |
| 8-K Filing | 2026-01-28 | English | |
| 25-NSE Filing | 2026-01-14 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 34424401 | 10-Q - Lexaria Bioscience Corp. (0001348362) (Filer) | 2026-04-13 | English | ||
| 32976920 | 4 - Lexaria Bioscience Corp. (0001348362) (Issuer) | 2026-03-18 | English | ||
| 29022250 | 8-K Filing | 2026-02-06 | English | ||
| 29022322 | S-8 Filing | 2026-01-28 | English | ||
| 29022316 | 8-K Filing | 2026-01-28 | English | ||
| 29022352 | 25-NSE Filing | 2026-01-14 | English | ||
| 29022243 | 424B3 Filing | 2026-01-14 | English | ||
| 29022297 | 10-Q Filing | 2026-01-13 | English | ||
|
2025
7 filings
| |||||
| 11930106 | FORM S-1 | 2025-12-29 | English | ||
| 11930109 | Regulatory Filings 2025 | 2025-12-19 | English | ||
| 11930112 | FORM 8-K | 2025-12-16 | English | ||
| 11930113 | 424B5 | 2025-12-16 | English | ||
| 11930117 | FORM DEF 14A | 2025-12-10 | English | ||
| 11930115 | Regulatory Filings 2025 | 2025-12-10 | English | ||
| 11930118 | 424B3 | 2025-12-09 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
DG INNOVATE PLC
Develops sustainable technologies for electric mobility and…
|
DGI | GB | Professional, scientific and te… |
|
Dianthus Therapeutics, Inc. /DE/
Clinical-stage biotech developing therapies for severe auto…
|
DNTH | US | Professional, scientific and te… |
|
DIMERIX LIMITED
Develops GPCR-targeted therapies for inflammatory kidney an…
|
DXB | AU | Professional, scientific and te… |
|
Dogwood Therapeutics, Inc.
A biotech company developing novel therapeutics for pain an…
|
DWTX | US | Professional, scientific and te… |
|
DORSAVI LTD
Develops clinical-grade wearable sensors and software for h…
|
DVL | AU | Professional, scientific and te… |
|
DreamCIS INC.
Contract research organization for pharma, biotech, and med…
|
223250 | KR | Professional, scientific and te… |
|
DT&CRO CO., Ltd.
A full-service CRO providing non-clinical and clinical stud…
|
383930 | KR | Professional, scientific and te… |
|
Dundee Sustainable Technologies Inc.
Develops proprietary, sustainable metallurgical processes f…
|
DST | CA | Professional, scientific and te… |
|
D.Western Therapeutics Institute, Inc.
Biotechnology firm developing drugs from a proprietary prot…
|
4576 | JP | Professional, scientific and te… |
|
Ecopia BioSciences Inc.
Developing novel anticancer agents and therapeutic solution…
|
EIA | CA | Professional, scientific and te… |
Lexaria Bioscience Corp. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34983/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34983 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34983 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34983 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34983}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Lexaria Bioscience Corp. (id: 34983)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.